Suppliers / Eisai

Eisai

Japan ESAIY Updated 9 July 2026

Eisai is an API and finished-dose manufacturer based in Japan. It appears in 526 regulatory filings across 26 regulators, without an active US DMF or CEP on file. Its filings concentrate with AIFA (IT), Health Canada and FAMHP (BE). Its GMP standing is certified by ZLG (DE), MFDS (Korea) and HSA (SG), among 6 authorities.

0
active US DMFs
0
valid CEPs
10
registered plants
526
filings across 26 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Raleigh, United Arab Emirates Not on file
Zürich, Switzerland Not on file
Frankfurt Am Main, Germany Not on file
Frankfurt, Germany Not on file
HATFIELD, United Kingdom Not on file
-, Indonesia Not on file

4 further sites are on record.

What they file, and where

Molecule Regulators Docs
Eribulin SFDA (Saudi Arabia) 2

Also appears on these molecule pages

Betahistine finished dose Bexarotene finished dose Chlorzoxazone finished dose Donepezil finished dose Eperisone finished dose Eribulin API Lenvatinib finished dose Mecobalamin finished dose Perampanel finished dose Rabeprazole finished dose Rufinamide finished dose Safinamide finished dose
Show 3 more molecule pages
Silodosin finished dose Trimetazidine finished dose Zonisamide finished dose

Filings and GMP by regulator

Regulator Filings GMP certificates
AIFA (IT) 74 None
Health Canada 61 None
FAMHP (BE) 56 None
BPOM (ID) 32 None
EMA 28 1
AEMPS (ES) 27 None
ZLG (DE) None 4
MFDS (Korea) None 2
HSA (SG) None 2
MHRA (UK) None 2
ANVISA (Brazil) None 1

Scale

Year Revenue Exports Destinations
2025 $478K Not reported Not reported

Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.

Questions about Eisai

Does Eisai hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Eisai. It does have 526 filings with 26 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Eisai manufacture?
10 registered sites are on record, in United Arab Emirates, Switzerland, Germany and United Kingdom (Raleigh, Zürich and Frankfurt Am Main among others). Every site is listed on this page with the register it came from.
What does Eisai make?
1 molecule is on record against Eisai, including Eribulin. Each links through to that molecule's full manufacturer list.
Which regulators recognise Eisai's GMP?
Current GMP certificates are on record from ZLG (DE), MFDS (Korea), HSA (SG), MHRA (UK), ANVISA (Brazil) and 1 more. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Eisai comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Dr Reddy's Laboratories shares 1 molecule Natco Pharma shares 1 molecule Formosa Laboratories shares 1 molecule BrightGene Bio-Medical shares 1 molecule Wisdom Pharmaceutical shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Company filings
Revenue as reported